A pharmaceutical company's pilot study (40 patients per group) detected a mean hospital stay reduction of 2 days (SD = 4 days) from a new drug. For the full trial, the company wants 80% power to detect a clinically meaningful effect of $\Delta = 1.5$ days at $\alpha = 0.05$. How will the required sample size in the full trial compare to the pilot?